Diabetes
Data from Switzerland, Turkey and Japan advance knowledge in diabetes research
Published in Blood Weekly, June 22nd, 2006
Study 1: Older age at time of reaching end-stage renal disease in type 1 diabetes mellitus may significantly impact the demand for renal grafts.
According to a study from Switzerland, "Diabetes mellitus (DM) type 1 is an important contributor to end-stage renal disease (ESRD) among younger transplant recipients. However, little is known about the changes in epidemiological characteristics of this population. Especially, time to reach ESRD may have changed in type 1 diabetic patients referred for transplantation, resulting in higher age at time of grafting. Such time...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-06-22)
More Articles from Blood Weekly
- Blood Banking
New project aims to use genotyping to improve patient safety and blood transfusion compatibility - Blood Banking
Platelet additive solutions offer several advantages for platelet storage - Blood Safety
West Nile Virus safety policy developed by Canadian Blood Services more stringent than U.S. policy - Tissue Engineering
Pre-seeding menisci enhances vascularization and increases extra-cellular matrix - Tissue Engineering
Tissue-engineered bone grafts can be transferred to lesions lacking adequate blood supply - Abdominal Aortic Aneurysms
Endologix receives U.S. Food and Drug Administration approval for Visiflex Delivery System - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
